Literature DB >> 17687335

Public awareness that HPV is a risk factor for cervical cancer.

L A V Marlow1, J Waller, J Wardle.   

Abstract

We assessed awareness of human papillomavirus (HPV) in a population sample of British women (n=1620) using similar questions to those in a survey in 2002. Only 2.5% cited HPV as the cause of cervical cancer without prompting; up from 0.9% in 2002. Public education about HPV is urgently needed.

Entities:  

Mesh:

Year:  2007        PMID: 17687335      PMCID: PMC2360359          DOI: 10.1038/sj.bjc.6603927

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


There has been dramatic progress in understanding the role of human papillomavirus (HPV) in the aetiology of cervical cancer (Bosch and de Sanjosé, 2003). Human papillomavirus testing is likely to play a part in screening for cervical abnormalities (Cuzick ). Prophylactic HPV vaccination has been shown to be highly effective at preventing infection (Villa ), and is likely to be introduced in the United Kingdom in the near future. Despite the important public health implications of this work, knowledge about HPV in the general public appears to be low. Although surveys in Britain indicate that around 30% of young adults have ‘heard of’ HPV (Philips ; Waller ), this is probably little more than name recognition, because further questioning of women who say they are aware, found that fewer than half knew of the link with cervical cancer (Waller ; Tiro ). Using the open question ‘What causes cervical cancer’, the percentage mentioning HPV was less than 2% in surveys in the United Kingdom and Mexico (Lazcano-Ponce ; Waller ). The potential for a prophylactic vaccine has attracted a great deal of press coverage, and this may have increased knowledge of HPV. However, internet and newspaper articles are most likely to be accessed by higher SES groups (Pew Internet & American Life Project, 2006), so the educational impact could be stronger in more educated groups. The present study assessed awareness of HPV and knowledge of risk factors for cervical cancer in home-based interviews with a population-representative sample of British women. Responses were compared with results from a survey carried out in 2002 that used similar methods (Waller ), making it possible to analyse changes over time.

MATERIALS AND METHODS

Participants were women aged 16–97 years from a stratified random probability sampling frame. Data were collected as part of the NatCen (National Centre for Social Research) omnibus survey. Using the Post Office Address File (PAF), 6100 addresses in England, Wales and Scotland were selected for recruitment between November 2006 and February 2007. The selected addresses were sent a letter informing them about the research. Data were collected during face-to-face computer-assisted interviews. Women were first asked an open question; ‘Thinking of cervical cancer, what do you think is its main cause’. This was followed by ‘What, if any, are other causes of cervical cancer’. Women were prompted using the phrase ‘anything else’ to encourage multiple responses. This was the same format as used in the 2002 survey (Waller ). After that, women were asked a ‘closed’ awareness question: ‘Before this interview, were you aware of HPV’. This was asked after the open question to avoid it influencing their answers. Demographic information, including age, ethnicity, educational attainment and income, was also collected. Data were analysed using SPSS version 14.0. To assess associations between demographic factors and HPV awareness, each variable was entered individually into a logistic regression analysis. Data from the recall question were recoded so that any mention of a risk factor was included in the analysis and results were merged with the data from 2002 to analyse changes over time. Chi-square (χ2) analyses revealed some socio-demographic differences between the two samples, so log-linear analysis was used, controlling for potentially confounding variables.

RESULTS

There were 5585 eligible addresses at which 2981 productive interviews were carried out (response rate=53.4%). The questions in this survey were only asked in interviews with women (n=1620), but the recruitment method meant that response rates could only be calculated for both sexes. Respondents were aged 50 years on average and most were white (94%). See Table 1 for a breakdown of sample characteristics.
Table 1

Demographic characteristics of the sample and associations with HPV awareness (‘aware of HPV’)

  Awareness of HPV
Significance
  % N OR (95% CI) P-value
Age
 16–24 (n=138)15.2211.00 
 25–34 (n=260)27.0702.06 (1.20–3.54)0.008
 35–44 (n=307)29.0852.16 (1.28–3.67)0.004
 45–54 (n=262)30.8802.48 (1.45–4.22)0.001
 55–64 (n=252)29.9752.37 (1.39–4.06)0.002
 65–74 (n=210)18.9391.30 (0.73–2.33)0.374
 75+ (n=191)9.6180.59 (0.30–1.16)0.128
     
Ethnicity
 White (n=1521)24.23661.00 
 Asian or mixed Asian (n=38)23.790.97 (0.46–2.07)0.941
 Black or mixed black (n=35)17.660.67 (0.28–1.63)0.379
 Other (n=15)20.030.78 (0.22–2.79)0.783
     
Education
 No formal qualifications (n=536)12.7671.00 
 CSE/O-level (or equivalent) (n=466)17.5811.46 (1.03–2.07)0.035
 A-level (or equivalent) (n=219)27.1592.55 (1.72–3.79)<.001
 Higher education below degree (n=177)49.4876.73 (4.55–9.95)<.001
 Degree (n=209)44.9935.61 (3.86–8.17)<.001
     
Respondent income
 < £10 000 (n=763)18.91441.00 
 £10 000-£19 999 (n=357)24.8881.41 (1.05–1.91)0.025
 £20 000-£29 999 (n=150)42.3633.14 (2.16–4.55)0.000
 >£30 000 (n=74)46.6343.74 (2.28–6.12)0.000
 Missing (n=276)22.1591.22 (0.86–1.71)0.263

Awareness of HPV (recognition)

On the basis of the simple question about awareness of HPV that was asked at the end of the interview (the term ‘HPV’ was not used previously by the interviewer), a quarter of participants (24.2%, n=388) said they were aware of HPV. There were some age differences, with 29% of respondents who were in the cervical cancer screening age (25–64 years) reporting awareness of HPV compared with only 15% aged 16–24 years or 65 and over. Differences in HPV awareness by ethnic group were not significant, but awareness was lower in respondents with lower levels of education and income (see Table 1).

Recall of cervical cancer risk factors

Responses to the ‘open’ question about causes of cervical cancer are shown in Table 2. Around half of respondents answered ‘don’t know’ (51%), and only 2.5% mentioned HPV. Compared with those with no formal education, respondents were more likely to mention HPV if they were educated to A-level standard (OR=3.75, CI 1.05–13.41) or had a University degree (OR=10.28, CI 3.37–31.36). Respondents were also more likely to mention HPV if they had an annual income greater than £30 000 than if their income was less than £10 000 (OR=5.66, CI 2.34–13.72).
Table 2

Recall of risk factors for cervical cancer in 2002a and 2007

  2002 (n=1093)
2007 (n=1620)
 
  % N % N χ2 for difference over time (P-value)b
Sex-related factors
 Wart virus1.6180.8135.69 (0.017)
 Genital warts1.9210.7128.45 (0.004)
 Human papillomavirus (HPV)0.9102.5419.39 (0.002)
 Herpes virus0.9100.610NS
 Chlamydia infection1.5160.914NS
 HIV/AIDS0.780.46NS
 A sexually transmitted infection/disease (unspecified)5.9646.6107NS
 A virus/infection/disease (unspecified)2.1235.48721.48 (<0.001)
 Having many sexual partners29.632413.822499.54 (<0.001)
 Becoming sexually active at a young age12.81407.412024.45 (<0.001)
 Having more frequent sex4.7512.9476.07 (0.014)
 Not using condoms7.0773.15019.41 (<0.001)
 Sexual activity (unspecified)5.7624.573NS
      
Lifestyle factors      
 Smoking15.31676.811041.98 (<0.001)
 Taking the pill7.0771.21960.68 (<0.001)
 Not going for regular screening (smear tests)15.41684.77674.81 (<0.001)
 Having many pregnancies/children1.4150.711NS
 Low-fibre diet0.550.914NS
 High-fat diet1.1121.321NS
 Low-fruit and/or -vegetable diet1.1121.423NS
 Being overweight0.9100.712NS
 Stress0.9100.915NS
      
Biological factors      
 Immunosuppression0.330.3 NS
 Older age2.1231.017NS
 Younger age0.670.23NS
 Family history (a blood relative) who has/had cervical cancer15.51698.313431.82 (<0.001)
 Family history (a blood relative) who has/had cancer6.2683.15113.55 (<0.001)
      
Other      
 Fate/chance/bad luck4.3472.5416.49 (0.011)
 Nothing0.5511.8191141.67 (<0.001)
 Other9.91085.69095.81 (<0.001)
 Don’t know32.135050.98191202.74 (<0.001)
 Refusal0.220.610NS

NS=non-significant, P>0.05.

Results reported in Waller .

Analyses controlled for income and ethnicity.

Overall, 28% of respondents identified something associated with sexual activity: multiple sexual partners (14%), unspecified sexually transmitted virus/infection (7%), sex at a young age (7%), frequency of sex (3%), not using condoms (3%) or unspecified sexual activity (4%). Other sexually transmitted diseases (wart virus, genital warts, herpes, chlamydia and HIV/AIDS) were cited by 2% of respondents. Additional responses included a virus/infection not specifying transmission type (5%), smoking (7%), and not going for regular screening (5%).

Change in knowledge of cervical cancer risk factors over time

Respondents from 2007 had slightly higher incomes (χ2(3)=9.36, P=0.025) and were less likely to be in ethnic minority groups (χ2(4)=14.36, P=0.006) than respondents from 2002. Further analyses controlled for these variables. Compared with results from 2002, there was a modest but significant increase in the number of respondents citing HPV as a risk factor for cervical cancer (from 0.9 in 2002 to 2.5% in 2007), and an increase in the number of respondents who mentioned virus/infection (from 2 to 5%). However, fewer respondents mentioned other factors relating to sexual activity, including number of sexual partners (2002: 30%, 2007: 14%), sex at a young age (13–7%), and not using condoms (7–3%). There were also significant decreases in citing wart virus (2–1%), genital warts (2–1%), not attending for smears (15–5%), smoking (15–7%), the pill (7–1%), older age (2–1%) and family history of cervical cancer (16–8%).

DISCUSSION

In this survey, a quarter of respondents answered ‘yes’ to the question ‘Were you aware of HPV’; which is similar to previous findings in selected samples in the United Kingdom (Waller ). As predicted, awareness was lower in those with less formal education, similar to disparities observed in knowledge about risk factors for other preventable cancers such as lung and skin (Viswanath ). Despite relatively high HPV name recognition, only 2.5% of respondents could spontaneously name HPV as a cause of cervical cancer, although this represents nearly a three-fold increase since 2002. There was also an increase in the proportion of respondents who mentioned virus/infection as a risk factor, but no increase in mention of ‘a sexually transmitted’ virus/infection. These results suggest that information about the viral aetiology of cervical cancer has trickled into the population since 2002, but understanding of how the virus is transmitted has not improved. It is striking that despite all the publicity about HPV, the percentage of the population who can recall that a viral infection is involved in cervical cancer, let alone which infection, is still extraordinarily low (<10%). What has also emerged, as predicted, is a significant SES gradient in awareness of HPV. Public understanding of HPV is necessary to ensure informed consent for vaccination and testing. There is therefore an urgent need for educational programmes. Given that lower SES is known to be associated with lower attendance at cervical screening (e.g., Webb ), raising awareness about HPV in these groups is particularly important. Health education initiatives should include specific efforts to reach lower SES groups, who have the lowest awareness but are at greatest risk.
  10 in total

1.  Cancer knowledge and disparities in the information age.

Authors:  K Viswanath; Nancy Breen; Helen Meissner; Richard P Moser; Bradford Hesse; Whitney Randolph Steele; William Rakowski
Journal:  J Health Commun       Date:  2006

2.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.

Authors:  Luisa L Villa; Ronaldo L R Costa; Carlos A Petta; Rosires P Andrade; Kevin A Ault; Anna R Giuliano; Cosette M Wheeler; Laura A Koutsky; Christian Malm; Matti Lehtinen; Finn Egil Skjeldestad; Sven-Eric Olsson; Margareta Steinwall; Darron R Brown; Robert J Kurman; Brigitte M Ronnett; Mark H Stoler; Alex Ferenczy; Diane M Harper; Gretchen M Tamms; Jimmy Yu; Lisa Lupinacci; Radha Railkar; Frank J Taddeo; Kathrin U Jansen; Mark T Esser; Heather L Sings; Alfred J Saah; Eliav Barr
Journal:  Lancet Oncol       Date:  2005-05       Impact factor: 41.316

3.  Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico.

Authors:  E Lazcano-Ponce; L Rivera; E Arillo-Santillán; J Salmerón; M Hernández-Avila; N Muñoz
Journal:  Arch Med Res       Date:  2001 May-Jun       Impact factor: 2.235

Review 4.  Chapter 10: New dimensions in cervical cancer screening.

Authors:  Jack Cuzick; Marie Helene Mayrand; Guglielmo Ronco; Peter Snijders; Jane Wardle
Journal:  Vaccine       Date:  2006-06-23       Impact factor: 3.641

5.  What do women in the U.S. know about human papillomavirus and cervical cancer?

Authors:  Jasmin A Tiro; Helen I Meissner; Sarah Kobrin; Veronica Chollette
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-01-30       Impact factor: 4.254

6.  A population-based study of primary care predictors of non-attendance for cervical screening.

Authors:  R Webb; J Richardson; A Pickles
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

7.  Beliefs about the risk factors for cervical cancer in a British population sample.

Authors:  Jo Waller; Kirsten McCaffery; Jane Wardle
Journal:  Prev Med       Date:  2004-06       Impact factor: 4.018

8.  Human papillomavirus and the value of screening: young women's knowledge of cervical cancer.

Authors:  Zoë Philips; Stacy Johnson; Mark Avis; David K Whynes
Journal:  Health Educ Res       Date:  2003-06

Review 9.  Chapter 1: Human papillomavirus and cervical cancer--burden and assessment of causality.

Authors:  F Xavier Bosch; Silvia de Sanjosé
Journal:  J Natl Cancer Inst Monogr       Date:  2003

10.  Awareness of human papillomavirus among women attending a well woman clinic.

Authors:  J Waller; K McCaffery; S Forrest; A Szarewski; L Cadman; J Wardle
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

  10 in total
  48 in total

1.  HPV infection awareness and self-reported HPV vaccination coverage in female adolescent students in two German cities.

Authors:  F Samkange-Zeeb; L Spallek; S J Klug; H Zeeb
Journal:  J Community Health       Date:  2012-12

2.  HPV Awareness, Knowledge and Vaccination Attitudes among Church-going African-American Women.

Authors:  Sarah B Maness; Lorraine R Reitzel; Kellie L Watkins; Lorna H McNeill
Journal:  Am J Health Behav       Date:  2016-11

3.  Changes in knowledge of cervical cancer prevention and human papillomavirus among women with human immunodeficiency virus.

Authors:  L Stewart Massad; Charlesnika T Evans; Kathleen M Weber; Johanna L Goderre; Nancy A Hessol; Donna Henry; Christine Colie; Howard D Strickler; D Heather Watts; Tracey E Wilson
Journal:  Obstet Gynecol       Date:  2010-10       Impact factor: 7.661

4.  Variation in blame attributions across different cancer types.

Authors:  Laura A V Marlow; Jo Waller; Jane Wardle
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-15       Impact factor: 4.254

5.  Knowledge and Awareness of HPV Infection and Vaccination Among Urban Adolescents in India: A Cross-Sectional Study.

Authors:  Krishna Kavita Ramavath; Roza Olyai
Journal:  J Obstet Gynaecol India       Date:  2013-06-27

6.  Role of men in promoting the uptake of HPV vaccinations: focus groups' finding from a developing country.

Authors:  Li Ping Wong
Journal:  Int J Public Health       Date:  2009-09-22       Impact factor: 3.380

7.  Coverage of Jade Goody's cervical cancer in UK newspapers: a missed opportunity for health promotion?

Authors:  Shona Hilton; Kate Hunt
Journal:  BMC Public Health       Date:  2010-06-24       Impact factor: 3.295

8.  Parental attitudes and information needs in an adolescent HPV vaccination programme.

Authors:  R Stretch; S A Roberts; R McCann; D Baxter; G Chambers; H Kitchener; L Brabin
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

9.  Development of a measurement tool to assess public awareness of cancer.

Authors:  S Stubbings; K Robb; J Waller; A Ramirez; J Austoker; U Macleod; S Hiom; J Wardle
Journal:  Br J Cancer       Date:  2009-12-03       Impact factor: 7.640

10.  Newsprint media representations of the introduction of the HPV vaccination programme for cervical cancer prevention in the UK (2005-2008).

Authors:  Shona Hilton; Kate Hunt; Mairi Langan; Helen Bedford; Mark Petticrew
Journal:  Soc Sci Med       Date:  2010-01-11       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.